The Critical Path Institute has chosen Steven Broadbent as its new chief operating officer. Since early 2009, Broadbent has been the director of consortia operations at the institute. Before joining C-Path, Broadbent was an executive at IBM for nearly 31 years.
Broadbent will take over for Rick Myers, who recently stepped down from the post in order to focus on his role as chairman of the Arizona Board of Regents. Myers will remain a member of C-Path's board of directors.
Knome has named Jay Therrien as its new senior VP and head of global sales, Charles Abdalian as chief financial officer, and Adam Rosenberg as senior VP and head of corporate development.
Previously, Therrien was VP of commercial operations and sequencing at Life Technologies, and also had spent five years in various sales leadership roles at Illumina. Abdalian recently was senior VP and CFO of Molecular Insight Pharmaceuticals, and he was senior VP of finance and CFO at Coley Pharmaceutical. Rosenberg previously was an adviser for emerging life sciences companies, co-founder of Clean Membranes, and CEO of Link Medicine.
The company also has appointed Hugh Reinhoff to serve on its scientific advisory board. Reinhoff is currently a managing director of Life Science Venture Partners, an adjunct scientist at the Children's Hospital Oakland Research Institute, and CEO of FerroKin BioSciences.